The Evolution of Canaloplasty - Scorecard - MDSpire

The Evolution of Canaloplasty

  • By

  • John S. McInnes, MD, JD

  • Nathan M. Radcliffe, MD

  • Cynthia Mattox, MD

  • John S. McInnes, MD, JD

  • Nathan M. Radcliffe, MD

  • Cynthia Mattox, MD

  • John S. McInnes, MD, JD

  • Nathan M. Radcliffe, MD

  • Cynthia Mattox, MD

  • May 1, 2026

  • 5 min

Share

Clinical Scorecard: The Evolution of Canaloplasty

At a Glance

CategoryDetail
ConditionOpen-Angle Glaucoma
Key MechanismsIntraluminal dilation of Schlemm’s canal and placement of implantable bioscaffold to enhance aqueous outflow and lower intraocular pressure (IOP).
Target PopulationPatients with open-angle glaucoma.
Care SettingOphthalmology surgical settings.

Key Highlights

  • Canaloplasty enhances Schlemm’s canal function through dilation and scaffolding.
  • Ab interno techniques are emerging as less invasive alternatives to traditional methods.
  • Canaloplasty shows greater IOP reduction compared to viscoelastic-only dilation.
  • New implantable scaffolding materials are being developed for improved outcomes.
  • CPT code 66175 is associated with canaloplasty procedures.

Guideline-Based Recommendations

Diagnosis

  • Assess Schlemm’s canal diameter and function using imaging techniques.

Management

  • Consider canaloplasty for patients with inadequate IOP control.

Monitoring & Follow-up

  • Regularly monitor IOP and canal patency post-procedure.

Risks

  • Potential complications include canal collapse and inadequate IOP reduction.

Patient & Prescribing Data

Adults with open-angle glaucoma experiencing elevated IOP.

Canaloplasty may provide a durable solution for IOP management.

Clinical Best Practices

  • Utilize ab interno approaches to minimize invasiveness.
  • Incorporate novel scaffolding materials for enhanced canal support.
  • Follow established CPT coding for procedural documentation.

References

Original Source(s)

Related Content